OHSU Knight Cancer Institute tapped for participation in a national consortium to accelerate cancer drug discovery

As the only center in the Pacific Northwest, OHSU will collaborate with other selected centers to address unmet needs in cancer therapy

By Amanda Gibbs December 20, 2022 Portland, Oregon

Downloads

Sanjay Malhotra Ph.D.

Shivaani Kummar, M.D. (OHSU)

Sanjay Malhotra and Shivaani Kummar

Shivaani Kummar, M.D., head of the division of hematology and medical oncology in the OHSU School of Medicine, and Sanjay Malhotra, Ph.D., right, are co-directors of the Knight Cancer Institute’s Center for Experimental Therapeutics. Malhotra is a professor in the departments of cell, developmental and cancer biology and oncological sciences in the OHSU School of Medicine. (OHSU/Christine Torres Hicks)

Brian Druker, M.D.

Dr. Brian Druker, director of the OHSU Knight Cancer Institute, at the opening of the Knight Cancer Research Building at OHSU, September 7, 2018. (OHSU/Kristyna Wentz-Graff)

Knight Cancer Institute Research

The Knight Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center between Sacramento and Seattle — an honor earned only by the nation's top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials. (OHSU/Christine Torres Hicks)